Overdose Avoidance and Patient Safety Law Approved by House

June 25, 2018

 

The Overdose Avoidance and Patient Safety Act – H.R. 6082 – goals to reduce limitations on the sharing of health files of patients with habits, aligning 42 CFR Part 2 – Secrecy of Substance Use Illness Patient Records – with HIPAA.

Presently, 42 CFR Part 2 only allows the exposure of health records of patients with substance misuse illness without written approval to medical workforce in crisis circumstances, to specified people for research and program assessments, or if needed to do so by means of a court order.

Under existing rules, a special release form should be signed by a patient allowing the addition of substance abuse illness information in their medical document.

Avoiding physicians from having access to a patient’s complete medical record means decisions might be taken without complete knowledge of their possible results. If particulars of substance abuse illness can be accessed, physicians will be able to make more updated decisions which will assist them to securely and effectively cure patients.

The Overdose Avoidance and Patient Safety Law lets the health records of substance abuse illness patients to be unveiled without written approval from patients for the purposes of cure, payment, and healthcare jobs, bring into line with the HIPAA Secrecy Law.

Moreover, the criminal fines for breaches involving substance abuse illness records would bring into line with the fine structure of HIPAA and would not be handled separately.

Secrecy safeguards are also improved for patients, which will forbid the use of SUD information in criminal and civil trial cases, will safeguard against prejudice by barring the sharing of substance abuse discover information with bosses and landowners, and would need notices to be issued in the event of the infringement of that information in accordance with the prerequisites of the HITECH Law.

The House passed the Overdose Avoidance and Patient Safety Law with a vote of 357-57. The Law will now go to the Senate legislative chamber for deliberation.